Encouraging results of preserving ovarian function after allo-HSCT with RIC

Bone Marrow Transplantation

Volumn 47, Issue 1, 2012, Pages 141-142

  Shimizu, M ^a   Sawada, A ^a   Yamada, K ^a   Kondo, O ^a   Koyama Sato, M ^a   Shimizu, S ^a   Komura, H ^a   Yasui, M ^a   Inoue, M ^a   Kawa, K ^a  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; FLUDARABINE; LYMPHOCYTE ANTIBODY; MELPHALAN; THIOTEPA;

ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; AMENORRHEA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; EPSTEIN BARR VIRUS ASSOCIATED T NATURAL KILLER CELL LYMPHOPROLIFERATIVE DISEASE; FEMALE; HORMONE SUBSTITUTION; HUMAN; LETTER; LYMPHOPROLIFERATIVE DISEASE; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; OVARY FUNCTION; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; OVARIAN DISEASES; OVARY; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 84855749596     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.14     Document Type: Letter

References (9)

1. Bresters D, van Gils IC, Kollen WJ, Ball LM, Oostdijk W, van der Bom JG et al. High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study. Bone Marrow Transplant 2010; 45: 79-85.
2. Socié G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood 2003; 101: 3373-3385. (Pubitemid 36857917)
3. Tauchmanovà L, Selleri C, De Rosa G, Esposito M, Orio Jr F, Palomba S et al. Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies. Hum Reprod 2003; 18: 1410-1416. (Pubitemid 36840946)
4. Brougham MF, Wallace WH. Subfertility in children and young people treated for solid and haematological malignancies. Br J Haematol 2005; 131: 143-155. (Pubitemid 43899679)
5. Nakagawa K, Kanda Y, Yamashita H, Nagakawa S, Sasano N, Ohtomo K et al. Ovarian shielding allows ovarian recovery and normal birth in female hematopoietic SCT recipients undergoing TBI. Bone Marrow Transplant 2008; 42: 697-699.
6. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996; 87: 3045-3052.
7. Marquis A, Kuehni CE, Strippoli MP, Kühne T, Brazzola P. Sperm analysis of patients after successful treatment of childhood acute lymphoblastic leukemia with chemotherapy. Pediatr Blood Cancer 2010; 55: 208-210.
8. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. WHO Classification of Tumor of Haematopoietic and Lymphoid Tissues, 4th edn. IARC Press: Lyon, France, 2008.
9. Kawa K, Sawada A, Sato M, Okamura T, Sakata N, Kondo O et al. Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection. Bone Marrow Transplant 2010; 46: 77-83.